High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.
about
The Biology of Monocytes and Dendritic Cells: Contribution to HIV Pathogenesis.The Peripheral and Intratumoral Immune Cell Landscape in Cancer Patients: A Proxy for Tumor Biology and a Tool for Outcome Prediction.When worlds collide: Th17 and Treg cells in cancer and autoimmunity.Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors.Targeting Tumor-Associated Macrophages as a Potential Strategy to Enhance the Response to Immune Checkpoint Inhibitors.Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment.Melanoma Immunotherapy: Next-Generation Biomarkers.Immuno-Oncology: Emerging Targets and Combination TherapiesCurrent landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitorsCTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patientsKeeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in CancerBiomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and BeyondFuture prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistanceBiomarkers for Immune Checkpoint Inhibitors in MelanomaPrognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New EvidencesMulti-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-OncologyBiomarkers for predicting efficacy of PD-1/PD-L1 inhibitorsThe role of automated cytometry in the new era of cancer immunotherapyCombination immuno-oncology therapy with pembrolizumab, an anti-PD-1 monoclonal antibody targeting immune evasion, and standard chemotherapy for patients with the squamous and non-squamous subtypes of non-small cell lung cancerCirculating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung CancerIntegrating Immunology and Microfluidics for Single Immune Cell Analysis
P2860
Q50131761-6F06FD55-2AD3-42F4-934C-670A7FB352F5Q52679182-2214C256-A805-41F7-9B9D-9CDA272CC060Q52689973-670D3CA5-B3CA-488F-952E-92CB34E42FDAQ54218762-084C39A2-3A47-4863-A722-4A807DF8B93DQ55007836-4F1262B3-43C8-4BDF-A851-AB39C45067F2Q55019711-2D708393-16E3-4ABE-9E75-ACBA91A595A4Q55114350-B178BA0F-50A4-403B-9F92-96905F2CBBD0Q55156734-5A002065-59E3-4502-86EA-913C812BB4DFQ56889817-5623A676-5892-4C99-8B39-4070ED8C5FBFQ56890243-F1D2F480-45EC-4118-AB0D-A52AFCD6A6CDQ56891027-7B91CB37-2572-4600-A73B-6995A94FE8E0Q56891212-0F61DFA2-43FE-4AB6-874F-CF1117D2C798Q56891609-EEDFDF5E-9E28-4BED-9366-3F66788D85D1Q57167969-5C6EC88E-0D84-473B-BA27-FF97887D2251Q57175477-084BC637-1E95-46D0-B75C-7FE2F3AE171DQ57191808-62ED7C71-EECF-4DC9-8F56-7F159C4B46A8Q57818011-0A0D2FF3-C0AF-42DC-BD90-4ECC5256E18BQ58713932-BA59BAC4-2815-4C30-B8D2-B695DCFB0652Q58733431-F64D86A4-5649-4680-A56E-BA09F8E1788CQ58770914-F9ECC5A7-61AA-45A8-A4D6-45F19A26E12BQ58801896-DD2E441D-3E88-4A22-83D7-F723A938E38DQ59136363-195A587B-7ECC-472C-9771-540A0B9A9C20
P2860
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.
@en
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.
@nl
type
label
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.
@en
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.
@nl
prefLabel
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.
@en
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.
@nl
P2093
P2860
P50
P356
P1433
P1476
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.
@en
P2093
Malgorzata Nowicka
Reinhard Dummer
Silvia Guglietta
P2860
P2888
P304
P356
10.1038/NM.4466
P407
P50
P577
2018-01-08T00:00:00Z